Key facts
- This page summarizes Joseph F. Gordon's Form 4 filing for Bausch Health Companies Inc. (BHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Mar 2022, 15:03.
Joseph F. Gordon - 08 Mar 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)
- Reporting relationship
- Pres&Co-Head Bausch&Lomb/Int'l
- Issuer ticker
- BHC
- Reported as of
- 08 Mar 2022
- Net transaction value
- -$84,625
- SEC form
- 4
- Accepted by SEC
- 10 Mar 2022, 15:03:45 UTC
- Prior SEC filing
- 07 Mar 2022
- Next SEC filing
- 05 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Debra E. Levin, attorney-in-fact for Joseph F. Gordon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Joseph F. Gordon filed Form 4 for Bausch Health Companies Inc. (BHC) on 10 Mar 2022.
Change
- Previous filing in this sequence was filed on 07 Mar 2022.
- Current net transaction value: -$84,625.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BHC
transaction
Common Shares, No Par Value
Sale
- Transaction value
- $84,625
- Shares
- -3,889
- Change %
- -4%
- Price
- $21.76
- Shares after
- 93,139
- Date
- 08 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021.